Elanix Biotechnologies AG (FRA:ELN) Equity-to-Asset : -1.30 (As of Dec. 2018)

Elanix Biotechnologies AG Equity-to-Asset Chart

Elanix Biotechnologies AG Annual Data
	Trend	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18
Equity-to-Asset		Get a 7-Day Free Trial					0.84	0.71	0.71	0.22	-1.30

Elanix Biotechnologies AG Semi-Annual Data
	Dec08	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18
Equity-to-Asset	Get a 7-Day Free Trial															0.71	0.76	0.22	0.71	-1.30

Competitive Comparison of Elanix Biotechnologies AG's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elanix Biotechnologies AG's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's Equity-to-Asset falls into.

Elanix Biotechnologies AG Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Elanix Biotechnologies AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2018 is calculated as

Elanix Biotechnologies AG's Equity to Asset Ratio for the quarter that ended in Dec. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elanix Biotechnologies AG  (FRA:ELN) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Elanix Biotechnologies AG Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Elanix Biotechnologies AG (FRA:ELN) Business Description